Autologous stem cell transplantation as first line treatment after incomplete excision of pancreatoblastoma
Rev. bras. hematol. hemoter
;
35(2): 148-148, 2013.
Article
in English
| LILACS
| ID: lil-676322
ABSTRACT
Pancreatoblastoma is a rare tumor and surgery with complete resection is the main treatment approach. Prognosis for patients with residual disease after surgery is usually dismal. A 14-year-old girl with pancreatoblastoma in the pancreatic body and tail was submitted to preoperative chemotherapy. She underwent surgery and the tumor was resected with microscopic margins. Postoperative chemotherapy was followed by high dose chemotherapy and autologous hematopoietic stem cell transplantation. After four years she remains very well with no evidence of disease. This is the first case reported of pancreatoblastoma that was treated with autologous hematopoietic stem cell transplantation as first line treatment without radiotherapy at the site of the microscopic disease.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Pancreatic Neoplasms
/
Transplantation, Autologous
/
Primary Treatment
/
Drug Therapy, Combination
Type of study:
Prognostic study
Limits:
Adolescent
/
Humans
Language:
English
Journal:
Rev. bras. hematol. hemoter
Journal subject:
Hematology
Year:
2013
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Centro de Oncologia e Hematologia de Mossoró/BR
/
Hospital Israelita Albert Einstein/BR
/
Universidade Federal do Rio Grande do Sul/BR
Similar
MEDLINE
...
LILACS
LIS